Windtree Therapeutics Inc
WINT
WINT was delisted on the 4th of May, 2017.
67 hedge funds and large institutions have $93.5M invested in Windtree Therapeutics Inc in 2014 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 13 reducing their positions, and 15 closing their positions.
79% more call options, than puts
Call options by funds: $828K | Put options by funds: $462K
54% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 13
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less funds holding
Funds holding: 73 → 67 (-6)
20% less capital invested
Capital invested by funds: $117M → $93.5M (-$23.1M)
40% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tamarack Capital Management
Carlsbad,
California
|
+$913K |
| 2 |
Millennium Management
New York
|
+$573K |
| 3 |
PRCM
Pine River Capital Management
Minnetonka,
Minnesota
|
+$365K |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$269K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$259K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$2.12M |
| 2 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$700K |
| 3 |
Morgan Stanley
New York
|
-$585K |
| 4 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
-$510K |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$458K |
WINT Hedge Fund Activity: Q2 2014 in Review
67 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Windtree Therapeutics Inc (WINT) for Q2 2014, worth a combined $93.5M — down 20% from $117M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of WINT and 9 opened new positions — a net loss of 6 holders — while 13 trimmed existing stakes and 20 added.
The largest buyer was Tamarack Capital Management, adding an estimated $913K. The largest seller was Wells Fargo, cutting an estimated $2.12M.
- 67 institutional investors held Windtree Therapeutics Inc (WINT) as of Q2 2014, down from 73 in Q1 2014.
- Funds reported $93.5M of Windtree Therapeutics Inc stock for Q2 2014, down 20% quarter-over-quarter.
- 9 funds opened new Windtree Therapeutics Inc positions in Q2 2014 and 15 closed out, a net change of -6 holders.
- The largest Windtree Therapeutics Inc buyer in Q2 2014 was Tamarack Capital Management, an estimated $913K added.
- The largest Windtree Therapeutics Inc seller in Q2 2014 was Wells Fargo, an estimated $2.12M sold.
Based on aggregated 13F filings for Q2 2014.